May 21 @ 12:00 pm – 12:30 pm PDT
Innovation Theater 2
Supported By GSK
Program Description
Patients with pulmonary conditions (e.g. asthma, chronic bronchitis, EGPA) can be immunocompromised due to their diseases or treatments. Identifying and managing the immunocompromised pulmonary patient can be challenging and complex. Interact with an expert pulmonologist and a professor of public health as they discuss a holistic approach to managing these patients through a case discussion of a pulmonary patient with EGPA.
An Industry Theater presentation at the ATS 2024 International Conference. This presentation is sponsored by GSK. Due to regulatory restrictions, this presentation is only available to attendees from the United States. This information is scientific and non-promotional in nature.
Speakers
Presenter: Kevin Winthrop, MD, MPH
Oregon Health & Science University
Infectious Disease and Opthamology
Professor
Portland, Oregon
OHSU-PSU
School of Public Health
Professor
Portland, Oregon
Presenter: Michael Wechsler, MD
National Jewish Health
Cohen Family Asthma Institute
Division of Pulmonary, Critical Care & Sleep Medicine
Pulmonologist
Denver, Colorado
Cohen Family Asthma Institute
Director
Denver, Colorado